JNJ Johnson & Johnson
NYSE · SEC CIK 200406 · EDGAR
- Bought, last 12 months
- $257.7K 1 purchases by 1 insiders
- Sold, last 12 months
- $154.85M 16 sales by 10 insiders
- Filings on record
- 335 since 2021-09-09, latest 2026-09-10 20:51
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Duato Joaquin | CEO, COB, Dir | — | $66.84M |
| Wolk Joseph J | EVP, CFO | — | $21.77M |
| REED JOHN C | EVP, Innovative Medicine, R, D | — | $17.29M |
| Swanson James D. | EVP, CIO | — | $15.11M |
| Schmid Timothy | EVP, WW COB, MedTech | — | $15.08M |
| Broadhurst Vanessa | EVP, Gbl Corp Affairs | — | $7.30M |
| Forminard Elizabeth | EVP, CLO | — | $4.09M |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | — | $3.95M |
| Wengel Kathryn E | EVP, Chief TO, Risk Off | — | $2.41M |
| Decker Robert J | VP Corp. Ctrl | — | $1.01M |
Transactions 353
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Mongon Thibaut | EVP, WW COB, Consumer | F - Tax | $165.89 | -1,843 | 43.9K | -4% | -$305.7K |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Wolk Joseph J | EVP, CFO | M - OptEx | $0.00 | +17.8K | 43.2K | +70% | $0 |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Wolk Joseph J | EVP, CFO | F - Tax | $165.89 | -7,319 | 35.9K | -17% | -$1.21M |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Wengel Kathryn E | EVP, Chief GSC Off | M - OptEx | $0.00 | +10.4K | 76.0K | +16% | $0 |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Wengel Kathryn E | EVP, Chief GSC Off | F - Tax | $165.89 | -4,699 | 71.3K | -6% | -$779.5K |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | McEvoy Ashley | EVP, WW COB, Medical Devices | M - OptEx | $0.00 | +15.8K | 48.1K | +49% | $0 |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | McEvoy Ashley | EVP, WW COB, Medical Devices | F - Tax | $165.89 | -6,242 | 41.8K | -13% | -$1.04M |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Mammen Mathai | EVP, Pharm, R, D | M - OptEx | $0.00 | +7,740 | 45.3K | +21% | $0 |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Mammen Mathai | EVP, Pharm, R, D | F - Tax | $165.89 | -3,366 | 41.9K | -7% | -$558.4K |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Gorsky Alex | Dir | M - OptEx | $0.00 | +61.0K | 611.9K | +11% | $0 |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Gorsky Alex | Dir | F - Tax | $165.89 | -26.5K | 585.4K | -4% | -$4.39M |
| D | 2022-02-17 06:00 | 2022-02-14 | JNJ | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $0.00 | +11.2K | 118.5K | +10% | $0 |
| D | 2022-02-17 06:00 | 2022-02-14 | JNJ | Fasolo Peter | EVP, Chief HR Off | F - Tax | $165.89 | -5,114 | 114.7K | -4% | -$848.4K |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Duato Joaquin | CEO, Dir | M - OptEx | $0.00 | +29.7K | 258.9K | +13% | $0 |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Duato Joaquin | CEO, Dir | F - Tax | $165.89 | -12.9K | 246.0K | -5% | -$2.14M |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Aff | M - OptEx | $0.00 | +2,557 | 16.6K | +18% | $0 |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Aff | F - Tax | $165.89 | -925 | 15.7K | -6% | -$153.4K |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Ullmann Michael H | EVP, GC | M - OptEx | $0.00 | +13.2K | 165.0K | +9% | $0 |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Ullmann Michael H | EVP, GC | F - Tax | $165.89 | -6,209 | 158.8K | -4% | -$1.03M |
| D | 2022-02-15 20:04 | 2022-02-14 | JNJ | Gorsky Alex | Dir | M - OptEx | $0.00 | +11.1K | 555.8K | +2% | $0 |
| D | 2022-02-15 20:04 | 2022-02-14 | JNJ | Gorsky Alex | Dir | F - Tax | $168.85 | -4,833 | 551.0K | -0.9% | -$816.1K |
| D | 2022-02-15 20:04 | 2022-02-14 | JNJ | Duato Joaquin | CEO, Dir | M - OptEx | $0.00 | +5,424 | 231.5K | +2% | $0 |
| D | 2022-02-15 20:04 | 2022-02-14 | JNJ | Duato Joaquin | CEO, Dir | F - Tax | $168.85 | -2,356 | 229.2K | -1% | -$397.8K |
| D | 2022-02-15 20:04 | 2022-02-14 | JNJ | Hait William | See Remarks | M - OptEx | $0.00 | +7,790 | 230.9K | +3% | $0 |
| D | 2022-02-15 20:04 | 2022-02-14 | JNJ | Hait William | See Remarks | F - Tax | $168.85 | -3,133 | 227.8K | -1% | -$529.0K |
| D | 2022-02-15 20:04 | 2022-02-14 | JNJ | Wolk Joseph J | EVP, CFO | M - OptEx | $0.00 | +3,248 | 26.3K | +14% | $0 |
| D | 2022-02-15 20:04 | 2022-02-14 | JNJ | Wolk Joseph J | EVP, CFO | F - Tax | $168.85 | -921 | 25.4K | -4% | -$155.5K |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Mammen Mathai | EVP, Pharm, R, D | M - OptEx | $0.00 | +7,418 | 39.9K | +23% | $0 |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Mammen Mathai | EVP, Pharm, R, D | F - Tax | $168.85 | -2,335 | 37.6K | -6% | -$394.3K |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Wengel Kathryn E | EVP, Chief GSC Off | M - OptEx | $0.00 | +1,896 | 66.3K | +3% | $0 |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Wengel Kathryn E | EVP, Chief GSC Off | F - Tax | $168.85 | -695 | 65.6K | -1% | -$117.4K |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Aff | M - OptEx | $0.00 | +2,451 | 14.9K | +20% | $0 |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Aff | F - Tax | $168.85 | -902 | 14.0K | -6% | -$152.3K |
| DM | 2022-02-15 20:03 | 2021-06-09 | JNJ | Ullmann Michael H | EVP, GC | G - Gift | $0.00 | -912 | 150.3K | -0.6% | $0 |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Ullmann Michael H | EVP, GC | M - OptEx | $0.00 | +2,407 | 152.7K | +2% | $0 |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Ullmann Michael H | EVP, GC | F - Tax | $168.85 | -871 | 151.9K | -0.6% | -$147.1K |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Mongon Thibaut | EVP, WW COB, Consumer | M - OptEx | $0.00 | +3,759 | 43.3K | +9% | $0 |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Mongon Thibaut | EVP, WW COB, Consumer | F - Tax | $168.85 | -1,520 | 41.8K | -4% | -$256.7K |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | McEvoy Ashley | EVP, WW COB, Medical Devices | M - OptEx | $0.00 | +2,885 | 33.0K | +10% | $0 |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | McEvoy Ashley | EVP, WW COB, Medical Devices | F - Tax | $168.85 | -792 | 32.2K | -2% | -$133.7K |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Decker Robert J | CAO, Ctrl | M - OptEx | $0.00 | +866 | 15.1K | +6% | $0 |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Decker Robert J | CAO, Ctrl | F - Tax | $168.85 | -263 | 14.8K | -2% | -$44.4K |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $0.00 | +2,036 | 109.4K | +2% | $0 |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Fasolo Peter | EVP, Chief HR Off | F - Tax | $168.85 | -743 | 108.6K | -0.7% | -$125.5K |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $0.00 | +3,297 | 118.4K | +3% | $0 |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | F - Tax | $168.85 | -1,190 | 117.2K | -1% | -$200.9K |
| DM | 2022-01-19 20:54 | 2021-12-09 | JNJ | Gorsky Alex | Dir | G - Gift | $0.00 | -12.6K | 463.7K | -3% | $0 |
| D | 2022-01-19 20:54 | 2022-01-14 | JNJ | Gorsky Alex | Dir | M - OptEx | $65.37 | +232.0K | 695.6K | +50% | +$15.16M |
| D | 2022-01-19 20:54 | 2022-01-14 | JNJ | Gorsky Alex | Dir | F - Tax | $167.84 | -150.9K | 544.7K | -22% | -$25.33M |
| D | 2022-01-19 20:54 | 2022-01-14 | JNJ | Duato Joaquin | CEO, Dir | M - OptEx | $65.37 | +84.4K | 280.5K | +43% | +$5.52M |
| D | 2022-01-19 20:54 | 2022-01-14 | JNJ | Duato Joaquin | CEO, Dir | F - Tax | $167.84 | -54.4K | 226.1K | -19% | -$9.13M |
| D | 2021-12-09 16:43 | 2021-12-07 | JNJ | Decker Robert J | CAO, Ctrl | M - OptEx | $72.54 | +5,000 | 19.2K | +35% | +$362.7K |
| D | 2021-12-09 16:43 | 2021-12-07 | JNJ | Decker Robert J | CAO, Ctrl | S - Sale+OE | $163.21 | -5,000 | 14.2K | -26% | -$816.0K |
Purchase Sale Sale after option exercise All abbreviations